journal article Open Access Oct 13, 2022

Intersection of the Ubiquitin–Proteasome System with Oxidative Stress in Cardiovascular Disease

View at Publisher Save 10.3390/ijms232012197
Abstract
Cardiovascular diseases (CVDs) present a major social problem worldwide due to their high incidence and mortality rate. Many pathophysiological mechanisms are involved in CVDs, and oxidative stress plays a vital mediating role in most of these mechanisms. The ubiquitin–proteasome system (UPS) is the main machinery responsible for degrading cytosolic proteins in the repair system, which interacts with the mechanisms regulating endoplasmic reticulum homeostasis. Recent evidence also points to the role of UPS dysfunction in the development of CVDs. The UPS has been associated with oxidative stress and regulates reduction–oxidation homeostasis. However, the mechanisms underlying UPS-mediated oxidative stress’s contribution to CVDs are unclear, especially the role of these interactions at different disease stages. This review highlights the recent research progress on the roles of the UPS and oxidative stress, individually and in combination, in CVDs, focusing on the pathophysiology of key CVDs, including atherosclerosis, ischemia–reperfusion injury, cardiomyopathy, and heart failure. This synthesis provides new insight for continued research on the UPS–oxidative stress interaction, in turn suggesting novel targets for the treatment and prevention of CVDs.
Topics

No keywords indexed for this article. Browse by subject →

References
104
[1]
Amini, M., Zayeri, F., and Salehi, M. (2021). Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: Results from global burden of disease study 2017. BMC Public Health, 21. 10.1186/s12889-021-10429-0
[2]
Virani "Heart Disease and Stroke Statistics-2021 Update: A Report from the American Heart Association" Circulation (2021) 10.1161/cir.0000000000000950
[3]
Travers "Therapeutic targets for cardiac fibrosis: From old school to next-gen" J. Clin. Investig. (2022) 10.1172/jci148554
[4]
Dzau "The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes: Part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease)" Circulation (2006) 10.1161/circulationaha.106.655688
[5]
Abdellatif "Autophagy in cardiovascular health and disease" Rog. Mol. Biol. Transl. Sci. (2020) 10.1016/bs.pmbts.2020.04.022
[6]
Organization, Cardiovascular Diseases (CVDs)—World Health Organization (2021, June 11). Definition of Cardiovascular Diseases. Available online: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
[7]
Hyun "Effects of Panax ginseng and ginsenosides on oxidative stress and car-diovascular diseases: Pharmacological and therapeutic roles" J. Ginseng Res. (2022) 10.1016/j.jgr.2021.07.007
[8]
Ferreira "Betanin as a multipath oxidative stress and inflammation modulator: A beetroot pigment with protective effects on cardiovascular disease pathogenesis" Crit. Rev. Food Sci. Nutr. (2022) 10.1080/10408398.2020.1822277
[9]
Jones "Radical-free biology of oxidative stress" Am. J. Physiol.-Cell Physiol. (2008) 10.1152/ajpcell.00283.2008
[10]
Jung "The proteasomal system" Mol. Aspects Med. (2009) 10.1016/j.mam.2009.04.001
[11]
Ciechanover "Intracellular protein degradation: From a vague idea thru the lysosome and the ubiquitin–proteasome system and onto human diseases and drug targeting" Biochim. Biophys. Acta (2012) 10.1016/j.bbapap.2011.03.007
[12]
Willis "The role of ubiquitin ligases in cardiac disease" J. Mol. Cell. Cardiol. (2014) 10.1016/j.yjmcc.2013.11.008
[13]
Brown "Ubiquitin Ligases and Posttranslational Regulation of Energy in the Heart: The Hand that Feeds" Compr. Physiol. (2017) 10.1002/cphy.c160024
[14]
Goto, J., Otaki, Y., Watanabe, T., and Watanabe, M. (2021). The Role of HECT-Type E3 Ligase in the Development of Cardiac Disease. Int. J. Mol. Sci., 22. 10.3390/ijms22116065
[15]
Demasi "Redox regulation of the proteasome via S-glutathionylation" Redox Biol. (2013) 10.1016/j.redox.2013.12.003
[16]
Goldstein "Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells" Proc. Natl. Acad. Sci. USA (1975) 10.1073/pnas.72.1.11
[17]
Ubiquitin Ligases: Structure, Function, and Regulation

Ning Zheng, Nitzan Shabek

Annual Review of Biochemistry 2017 10.1146/annurev-biochem-060815-014922
[18]
Trempe "Reading the ubiquitin postal code" Curr. Opin. Struct. Biol. (2011) 10.1016/j.sbi.2011.09.009
[19]
Finley "Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome" Annu. Rev. Biochem. (2009) 10.1146/annurev.biochem.78.081507.101607
[20]
Pickart "Mechanisms Underlying Ubiquitination" Annu. Rev. Biochem. (2001) 10.1146/annurev.biochem.70.1.503
[21]
"The Gentle Side of the UPS: Ubiquitin-Proteasome System and the Regulation of the Myogenic Program" Front. Cell Dev. Biol. (2021)
[22]
Morreale "Types of Ubiquitin Ligases" Cell (2016) 10.1016/j.cell.2016.03.003
[23]
Donohue "The ubiquitin-proteasome system and its role in ethanol-induced disorders" Addict. Biol. (2002) 10.1080/135562101200100562
[24]
Baumeister "The proteasome: A macromolecular assembly designed to confine proteolysis to a nanocompartment" Biol. Chem. (1997)
[25]
Oxidative stress: oxidants and antioxidants

H Sies

Experimental Physiology 1997 10.1113/expphysiol.1997.sp004024
[26]
Finkel "Signal Transduction by Mitochondrial Oxidants" J. Biol. Chem. (2012) 10.1074/jbc.r111.271999
[27]
Malhotra "Endoplasmic reticulum stress and oxidative stress: A vicious cycle or a double-edged sword?" Antioxid. Redox Signal. (2007) 10.1089/ars.2007.1782
[28]
Peroxisomes and oxidative stress

Michael Schrader, H.Dariush Fahimi

Biochimica et Biophysica Acta (BBA) - Molecular Ce... 2006 10.1016/j.bbamcr.2006.09.006
[29]
Gorrini "Modulation of oxidative stress as an anticancer strategy" Nat. Rev. Drug Discov. (2013) 10.1038/nrd4002
[30]
Gomes "Protein Degradation by the 26S Proteasome System in the Normal and Stressed Myocardium" Antioxid. Redox Signal. (2006) 10.1089/ars.2006.8.1677
[31]
Ishii "Oxidative Modification of Proteasome: Identification of an Oxidation-Sensitive Subunit in 26 S Proteasome" Biochemistry (2005) 10.1021/bi051336u
[32]
Yang "Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice" Hum. Mol. Genet. (2007) 10.1093/hmg/ddm249
[33]
Kevei "Reversible 26S Proteasome Disassembly upon Mitochondrial Stress" Cell Rep. (2014) 10.1016/j.celrep.2014.04.030
[34]
Suzuki "Stress-sensing mechanisms and the physiological roles of the Keap1–Nrf2 system during cellular stress" J. Biol. Chem. (2017) 10.1074/jbc.r117.800169
[35]
Homma "Emerging connections between oxidative stress, defective proteolysis, and metabolic diseases" Free Radic. Res. (2020) 10.1080/10715762.2020.1734588
[36]
Heckle "Atrophied cardiomyocytes and their potential for rescue and recovery of ventricular function" Heart Fail. Rev. (2016) 10.1007/s10741-016-9535-x
[37]
Versari "Dysregulation of the Ubiquitin-Proteasome System in Human Carotid Atherosclerosis" Arter. Thromb. Vasc. Biol. (2006) 10.1161/01.atv.0000232501.08576.73
[38]
Wilck "Targeting the Ubiquitin-Proteasome System in Atherosclerosis: Status Quo, Challenges, and Perspectives" Antioxid. Redox Signal. (2014) 10.1089/ars.2013.5805
[39]
Martin "Under construction: The dynamic assembly, maintenance, and degradation of the cardiac sarcomere" J. Mol. Cell. Cardiol. (2020) 10.1016/j.yjmcc.2020.08.018
[40]
Reyskens "HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system" Biochim. Biophys. Acta (2014) 10.1016/j.bbadis.2013.11.019
[41]
Nrf2 at the heart of oxidative stress and cardiac protection

Qin M. Chen, Anthony J. Maltagliati

Physiological Genomics 2018 10.1152/physiolgenomics.00041.2017
[42]
Zhou "Sirt3 Deficiency Increased the Vulnerability of Pancreatic Beta Cells to Oxidative Stress-Induced Dysfunction" Antioxid. Redox Signal. (2017) 10.1089/ars.2016.6859
[43]
Herrmann "On to the road to degradation: Atherosclerosis and the proteasome" Cardiovasc. Res. (2010) 10.1093/cvr/cvp333
[44]
Poznyak, A.V., Kashirskikh, D.A., Sukhorukov, V.N., Kalmykov, V., Omelchenko, A.V., and Orekhov, A.N. (2022). Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis. Int. J. Mol. Sci., 23. 10.3390/ijms23031332
[45]
Ishikawa "Heme oxygenase-1 inhibits athero-sclerotic lesion formation in ldl-receptor knockout mice" Circ. Res. (2001) 10.1161/01.res.88.5.506
[46]
Maxwell "The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis" Nature (1999) 10.1038/20459
[47]
Cockman "Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein" J. Biol. Chem. (2000) 10.1074/jbc.m002740200
[48]
Brand "Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion" J. Clin. Investig. (1996) 10.1172/jci118598
[49]
Karin "Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity" Annu. Rev. Immunol. (2000) 10.1146/annurev.immunol.18.1.621
[50]
Canty "Oxidative stress induces NF-kappaB nuclear translocation without degradation of IkappaBalpha" Circulation (1999)

Showing 50 of 104 references

Cited By
34
Metrics
34
Citations
104
References
Details
Published
Oct 13, 2022
Vol/Issue
23(20)
Pages
12197
License
View
Funding
National Natural Science Foundation of China Award: 82170259
Science and Technology Planning Project of Guangdong Province Award: 82170259
Science and Technology Program of Guangzhou, China Award: 82170259
Cite This Article
Min Qiu, Jimei Chen, Xiaohong Li, et al. (2022). Intersection of the Ubiquitin–Proteasome System with Oxidative Stress in Cardiovascular Disease. International Journal of Molecular Sciences, 23(20), 12197. https://doi.org/10.3390/ijms232012197
Related

You May Also Like